Rapamycin News - Latest News and Information
Technology Pulse
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
The phase 3 ACHIEVE‑3 trial showed that oral orforglipron outperformed oral semaglutide in both glycemic control and weight loss for type 2 diabetes patients. At 52 weeks, the 36 mg dose reduced HbA1c by 1.91% versus 1.47% for semaglutide and achieved an 8.2% weight reduction compared with 5.3%. Orforglipron also delivered higher rates of near‑normoglycemia (31% vs 12%) but caused more gastrointestinal side effects and a modest heart‑rate increase. The FDA approved the drug, branded Foundayo, on April 1 2026 at $149 per month.
A community thread explores a range of longevity interventions, from metabolic drugs like pioglitazone and Imeglimin to neuro‑activators such as modafinil and orexin‑targeting strategies. Participants share personal dosing experiences, highlight safety concerns—including heart‑failure and bladder‑cancer risks for pioglitazone and dangerous...
A recent Norwegian crossover study reported that nicotinamide riboside (NR) raised blood NAD levels 2.3‑fold higher than nicotinamide mononucleotide (NMN) in six healthy adults. However, a larger 65‑participant Nature Metabolism trial found both NR and NMN roughly doubled NAD after...
The University of Arizona’s R. Ken Coit College of Pharmacy is launching a double‑blind, randomized Phase 3 clinical trial to test low‑dose rapamycin’s ability to boost resilience and immune function in adults aged 65 and older. The six‑year study, funded by a...
The article presents a detailed three‑phase workflow for analyzing endothelial‑health genetic pathways, starting with evidence‑based SNP research, then producing a generic reference DOCX, and finally delivering a personalized report that maps genotype results to supplement and medication guidance. It mandates...
A short‑term ubiquinol regimen of 200 mg per day for two weeks boosted strength and endurance while lowering perceived exertion in moderately trained adults. Muscle‑damage biomarkers also fell, indicating protective effects after strenuous exercise. Separate meta‑analyses suggest CoQ10 supplementation can cut...
A recent deep‑dive genetic report examined 20 SNPs across nine pathways linked to endothelial function and coronary artery disease. The analysis identified homozygous risk variants in GUCY1A3, PCSK9, PDE5A, ICAM1, XDH and SPR that collectively blunt NO‑cGMP signaling and raise...
A personal genome analysis of 20 SNPs across nine functional categories identified critical vulnerabilities in nitric‑oxide signaling, highlighted by a double‑hit in GUCY1A3 and a PCSK9 gain‑of‑function variant that elevates LDL‑C. Additional risk alleles include a heterozygous 9p21 CAD locus,...
Investigative videos released by Mark Hyman and Jordan Peterson expose severe sepsis cases linked to experimental stem‑cell injections administered by Dr. Adil Khan’s unregulated regenerative‑medicine clinics. Hyman’s spinal injections for disc degeneration allegedly introduced a bacterial infection, while Peterson’s extensive...
Investigative videos reveal that wellness influencers Mark Hyman and Jordan Peterson suffered severe sepsis after receiving experimental stem‑cell and related injections from Dr. Adil Khan’s unregulated clinics. The series links spinal and intravenous therapies to bacterial infections, highlighting the doctors’...
Retatrutide, a next‑generation GLP‑1/GIP/Glucagon agonist, appears to cause less nausea than semaglutide while delivering comparable weight‑loss efficacy, but early data show a modest increase in resting heart rate. Patient anecdotes highlight typical GLP‑1 side effects—transient nausea, bowel habit shifts, occasional...
Investigative videos reveal that wellness influencers Mark Hyman and Jordan Peterson suffered severe sepsis after receiving experimental stem‑cell and related injections from Dr. Adil Khan’s unregulated clinics. The series links Hyman’s spinal abscess and Peterson’s pneumonia‑sepsis to a pattern of...
![[Cybersecurity Thread] ""Soon-to-Be-Released AI Models Could Enable a World-Shaking Cyberattack This Year", Protect Your Healthcare Data](/cdn-cgi/image/width=1200,quality=75,format=auto,fit=cover/https://hixhlmpcokxhartfkpyi.supabase.co/storage/v1/object/public/images/thumbnails/390c9bf9661af63f4fea98e27de10cde.webp)
Project Glasswing warns that soon‑to‑be‑released AI agents are vulnerable to hidden prompt injections and memory‑poisoning attacks, with success rates as high as 86% and 80% respectively. DeepMind has identified six attack layers—from perception to human supervision—demonstrating proof‑of‑concept exploits that could...
Rowan offers a cloud‑based quantum‑chemistry platform with free compute credits, enabling users to run GFN2‑xTB and other methods on complex molecules. In a rapamycin case study, the tool identified electrophilic hotspots concentrated in oxygen‑rich carbonyl/ester regions and mapped electron‑rich sites...
RowanSci’s recent run on rapamycin identified a suite of low‑frequency vibrational modes between 3 and 32 cm⁻¹, with a single small imaginary mode treated as a floppy coordinate. The analysis mapped these soft motions to the same atoms that exhibit the...
